Table 3 Treatment response evaluation to neoadjuvant chemotherapy using 11C-acetate PET/MRI. Patients 1 and 2 participated in both phases of the trial, underwent PET/MRI before any intervention and secondary PET/MRI was performed after completion of NAC. Patients 3–5 were enrolled after TUR-BT and underwent PET/MRI after completion of NAC. Imaging after NAC prior RC was compared to RC pathology
Patient | PET/MRI | RC | ||
|---|---|---|---|---|
Primary tumour | LNM +/− | Primary tumour | LN n tot / n+ | |
1 | T0 | + | T0 | 27 / 0 |
2 | T4 | + | T2 | 42 / 3 |
3a | T0 | – | T3 | 27 / 9 |
4 | T0 | – | T0 | 43 / 0 |
5 | T3 | – | T2 | 36 / 0 |
| Â | Â | Â | Â | 175 / 12 |